These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 20597673)

  • 21. Pharmacokinetic-pharmacodynamic considerations in the design of hospital-acquired or ventilator-associated bacterial pneumonia studies: look before you leap!
    Ambrose PG; Bhavnani SM; Ellis-Grosse EJ; Drusano GL
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S103-10. PubMed ID: 20597657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. End points in hospital-acquired pneumonia and/or ventilator-associated pneumonia clinical trials: food and drug administration perspective.
    Laessig KA
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S117-9. PubMed ID: 20597659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ventilator-associated pneumonia: what is new?
    Chastre J
    Surg Infect (Larchmt); 2006; 7 Suppl 2():S81-5. PubMed ID: 16895514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of recent international guidelines.
    File TM
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S42-7. PubMed ID: 20597671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled antibiotic therapy for ventilator-associated tracheobronchitis and ventilator-associated pneumonia: an update.
    Abu-Salah T; Dhand R
    Adv Ther; 2011 Sep; 28(9):728-47. PubMed ID: 21833701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. De-escalation therapy in ventilator-associated pneumonia.
    Niederman MS
    Curr Opin Crit Care; 2006 Oct; 12(5):452-7. PubMed ID: 16943725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis.
    Ioannidou E; Siempos II; Falagas ME
    J Antimicrob Chemother; 2007 Dec; 60(6):1216-26. PubMed ID: 17934205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.
    Jones RN
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S81-7. PubMed ID: 20597676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aerosolized antibiotics in critically ill ventilated patients.
    Palmer LB
    Curr Opin Crit Care; 2009 Oct; 15(5):413-8. PubMed ID: 19657273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit.
    Palmer LB; Smaldone GC; Chen JJ; Baram D; Duan T; Monteforte M; Varela M; Tempone AK; O'Riordan T; Daroowalla F; Richman P
    Crit Care Med; 2008 Jul; 36(7):2008-13. PubMed ID: 18552684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Registration trials of antibacterial drugs for the treatment of nosocomial pneumonia.
    Sorbello A; Komo S; Valappil T; Nambiar S
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S36-41. PubMed ID: 20597669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.
    Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A
    Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of quantitative cultures and reduced duration of antibiotic regimens for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit.
    Chastre J; Luyt CE; Combes A; Trouillet JL
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S75-81. PubMed ID: 16894519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia.
    Torres A; Ferrer M; Badia JR
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S48-53. PubMed ID: 20597672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiratory therapies in the critical care setting. Should aerosolized antibiotics be administered to prevent or treat ventilator-associated pneumonia in patients who do not have cystic fibrosis?
    MacIntyre NR; Rubin BK
    Respir Care; 2007 Apr; 52(4):416-21; discussion 421-2. PubMed ID: 17417976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ventilator-associated pneumonia: an overview.
    DiCocco JM; Croce MA
    Expert Opin Pharmacother; 2009 Jun; 10(9):1461-7. PubMed ID: 19505213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic resistance in nosocomial respiratory infections.
    Denys GA; Relich RF
    Clin Lab Med; 2014 Jun; 34(2):257-70. PubMed ID: 24856527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of ventilator-associated pneumonia.
    Diaz E; Ulldemolins M; Lisboa T; Rello J
    Infect Dis Clin North Am; 2009 Sep; 23(3):521-33. PubMed ID: 19665081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.
    Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
    Crit Care Med; 2007 Jan; 35(1):146-54. PubMed ID: 17080004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.